The Conservative Cave

Current Events => Breaking News => Topic started by: SVPete on December 31, 2021, 08:27:47 AM

Title: Maryland doctor says people are 'going to die' after Biden admin uses faulty ...
Post by: SVPete on December 31, 2021, 08:27:47 AM
Maryland doctor says people are 'going to die' after Biden admin uses faulty data to snub antibody treatments (

A doctor in Maryland said he had to cancel potentially life-saving monoclonal antibody infusions for about 250 people over the last week after the federal government stopped distributing treatments made by Regeneron and Eli Lilly because they aren't effective against omicron, even though the delta variant, which the drugs are effective at treating, was still dominant at the time.

The Office of the Assistant Secretary for Preparedness and Response halted the allocation of those two antibody treatments last Thursday amid the rise of omicron, which the CDC had said days earlier was responsible for 73.2% of all new cases.

But the CDC backtracked on that alarming estimate this week, revising it down to just 22.5% for the week ending Dec. 18, more than a 50-point drop.
"I am as angry as I possibly can be about this," Dr. Ron Elfenbein, the medical director and CEO of FirstCall Medical Center in Gambrills, Maryland, told Fox News Digital on Wednesday.

"The fact that these people are so adamant that they're right when they're using faulty data and they're using faulty logic and frankly statistical modeling that has never been correct, ever, throughout this entire pandemic, to look at this, is just beyond the pale…. People are definitely going to die because of this or need hospitalization because [health officials] misread the statistics."

This was one doctor at one hospital in one state!
Title: Re: Maryland doctor says people are 'going to die' after Biden admin uses faulty ...
Post by: SVPete on December 31, 2021, 08:47:26 AM
With a :greet: to Mr. Mannn:


While the availability of oral antivirals for treatment of COVID-19 is an important milestone, it
comes at a time of a significant surge in cases and reduced effectiveness of existing
therapeutics due to the omicron variant, which is now the predominant variant nationally and
estimated by the Centers of Disease Control and Prevention (CDC) to account for over 90% of
cases in New York. Supplies of oral antivirals will be extremely limited initially, and there is now
only one monoclonal antibody product that is effective for treatment of infection caused by the
omicron variant. While supplies remain low, adhere to the NYS DOH guidance on prioritization
of anti-SARS-CoV-2 therapies for treatment and prevention of severe COVID-19 and prioritize
therapies for people of any eligible age who are moderately to severely immunocompromised
regardless of vaccination status or who are age 65 and older and not fully vaccinated with at
least one risk factor for severe illness.
Oral antiviral treatment is authorized for patients who meet all the following criteria:
Have a medical condition or other factors that increase their risk for severe illness.
o Non-white race or Hispanic/Latino ethnicity should be considered a risk factor, as
longstanding systemic health and social inequities have contributed to an
increased risk of severe illness and death from COVID-19
Changes to Monoclonal Antibody Use
At this time, Sotrovimab (Xevudy) is the only authorized monoclonal antibody therapeutic that is
expected to be effective against the omicron variant of SARS-CoV-2. Supplies of Sotrovimab
are extremely limited and providers should adhere to NYS DOH prioritization guidance.
As of December 23, 2021, there is a pause on further allocations of bamlanivimab and
etesevimab together, etesevimab alone, and REGEN-COV beginning 1/3/2022. Bamlanivimab
with etesevimab and REGEN-COV do not retain activity against omicron. NYC providers
should refer to NYC's Letter to Providers: Omicron and Monoclonal Antibodies. Monoclonal
antibody treatment can no longer be used as post-exposure prophylaxis.

Sotrovimab, (marketing name "Xevudy" - don't ask me how to pronounce that!) was developed by Vir Biotechnology and GlaxoSmithKline and received Emergency Use Authorization May 26, 2021. W'pedia claims the Feds purchased 1.5 million doses of sotrovimab, but reading the source article for that claim the 1.5 million doses ordered were, instead, of Regeneron's REGEN-COV.
Title: Re: Maryland doctor says people are 'going to die' after Biden admin uses faulty ...
Post by: SVPete on December 31, 2021, 08:58:13 AM
From my posts about this to the Shoutbox:

The background to that NY racist policy is the LIEden Kovid Krew F-Up I linked above, (this thread's OP link).

The Eli Lilly and Regeneron mabs, SUPPOSEDLY, are ineffective against Omicron, and the Feds stopped distributing it when they got the stat that Omicron was 73.2% of Covid cases. I'm skeptical of this, but will look over Eli Lilly's and Regeneron's Press Releases webpages.

After God knows how many hundreds or thousands of people nationwide who had Covid were refused the treatments, because the Feds withheld the meds, the real numbers came it at 22.5% Omicron cases.

Those hundreds or (more probably) thousands could not receive effective mab treatments because LIEden's Krew micromanaged the supply wrongly using bogus data.

As for Pfizer's Paxlovid and Merck's Molnupiravir, LIEden's Kovid Krew chose not to do what Trump's OWS did, pre-order when test data started showing they were looking effective. I suspect LIEden's Kovid Krew also failed to order sotrovimab in significant quantity and in a timely way.

When Pfizer's and Moderna's vaccines were authorized, the companies had millions of doses ready to ship. Not so, Paxlovid and Molnupiravir. Trump's OWS also contracted for things necessary for the coming large scale vaccination program - syringes & needles, alcohol wipses, gauze pads, etc..

Failing to plan is planning to fail. LIEden's Krew's failure to plan probably cost scores of lives that shouldn't have been, and possibly hundreds of hospitalizations that should have been necessary.

Don't look for BMM and the rest of the Alphabet-Soupers or the WashPost-NYT Biden-Beholden Info-Guardians to cover (beyond de-fanged token mention) or investigate this LIEden Kovid Krew F-Up.
Title: Re: Maryland doctor says people are 'going to die' after Biden admin uses faulty ...
Post by: SVPete on December 31, 2021, 12:16:46 PM
Evidently the WashPost has an editorial about this LIEden Kovid Krew F-Up, WaPo editors *almost* get it: This administration is "flying blind" on pandemic: (

True enough, but the Washington Post editorial board misses an even more basic failure by the Biden administration. The board published an unsigned editorial late yesterday castigating the CDC and the FDA for not building a data-based approach to the COVID-19 pandemic, which has been a failing ever since it began. ...

The omicron variant of the covid-19 virus emerged around Thanksgiving. The first confirmed case in the United States was recorded Dec. 1, and the Centers for Disease Control and Prevention estimated the prevalence for the week ending Dec. 18 had soared to 73 percent — an astounding and alarming leap, virtually displacing the delta variant. Now, the CDC has revised that week’s estimate down to 22.5 percent, a correction that underscores how the United States is flying blind in the pandemic storm.

Undoubtedly, omicron will continue to rise, but the initial, overly high estimate is a symptom of a serious, systemic gap in public health information. We have the technology to chart the whole genome of a viral sample. But the United States has not yet built a real-time system of viral genomic surveillance that would allow comprehensive tracking of variants as they move through the population. As it is now, the CDC pulls together genomic surveillance data from a variety of sources, including its own facilities, state public health labs, and university and private laboratories, but only a fraction of all pandemic samples are sequenced, and it can take weeks to build a reliable picture of how the variant is spreading.

I disagree with Hot Air writer Ed Morrissey that the big story the WashPost editorial skipped over is short-supply of Covid tests during a surge. The big story from which I think the WashPost is trying to deflect attention is that this LIEden Kovid Krew F-Up has caused scores or hundreds of deaths, and even more hospitalizations, that should not have happened.